Pharma Journalist -

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as…
Read More...

Novartis announced the European Commission (EC) has approved Beovu (brolucizumab) injection for the treatment of wet age-related macular degeneration (AMD). Beovu is the first…
Read More...

Ascletis Pharma Inc. announces the application for in-house developed Category 1 Drug ASC41 for clinical trials of NASH indication has been accepted by China's National Medical Products…
Read More...

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as…
Read More...

PharmaMar and Jazz Pharmaceuticals plc announce that the U.S. Food and Drug Administration (FDA) accepted for filing with Priority Review the New Drug Application (NDA) seeking…
Read More...

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated an accelerated research programme with multiple teams in India and Europe developing a…
Read More...

PCI Pharma Services (PCI) announced the acquisition of Bellwyck Pharma Services (Bellwyck), headquartered in Toronto, Canada. With 25 years of experience, Bellwyck is a leader in…
Read More...

Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Company’s New Drug Application (NDA) for the investigational…
Read More...

Soligenix, Inc. announced that its RiVax (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication has received "Fast Track" designation from the US…
Read More...

Vir Biotechnology, Inc. a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, announced that it has identified two…
Read More...